Domain profile · Jun–Aug 2026Status · Live
callistobiomed.com↗
Callisto BioMed
#16,288,898Link-graph rank
Top 13.6%of 119.7M domains
PageRank #26,171,819By links pointing at it
1 hostSubdomains in the link graph
Technologies
Content & CMS · 1Commerce & payments · 1Infrastructure & security · 1
SquarespaceSquarespace CommerceHSTS
Site details
| Website | callistobiomed.com ↗ |
| Site language | American English |
| Last read | 1 Oct 2026 |
Similar sites
Sites ranked next to it
| Rank | Site | Description | Technologies | Language |
|---|---|---|---|---|
| 16288893 | Baerenkraft | WebflowGoogle Font API+5+6 | ||
| 16288894 | Profile of Dr. Sascha Berger, Global Investor and Strategic Advisor | CloudflareCloudflare Bot Management+1 | English | |
| 16288895 | Better Biostatistics – Biostatistician, 🧑🏼💻 Statistical Programmer, 👨🏼🏫 Life Sciences Educator | Google AnalyticsGoogle Tag Manager+8+9 | American English | |
| Ad | Serpex Search APIserpex.dev | The fast, affordable search API for AI & data projects. | Google AnalyticsNext.js | English |
| 16288896 | Breezy Point is a private family office. | HTTP/3Cloudflare+1 | English | |
| 16288897 | ButoBeiwe | GoDaddy Website BuilderHSTS+1 | American English | |
| 16288899 | Capital Global Partners | | DiviWordPress+5+6 | American English | |
| 16288901 | Crossignal Therapeutics is developing new generation of small molecule anti cancer immunotherapies. Get in touch with us today. | Apache HTTP Server | English | |
| 16288902 | Home | Azure Edge NetworkApache HTTP Server+1 | ||
| 16288903 | Cyana Therapeutics is a precision immuno-oncology company developing CY-3132, a small molecule ENPP1 inhibitor for the treatment of solid tumors. IND open, Phase 1 clinical trial planned for 2026. | HSTSNetlify+1 | English |
Is this your site? Request removal of the callistobiomed.com page.
